These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2125370)
1. D-dimer in local thrombolytic therapy with low doses of recombinant human tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease. Koppensteiner R; Speiser W; Minar E; Ahmadi R; Ehringer H Thromb Haemost; 1990 Oct; 64(2):192-5. PubMed ID: 2125370 [TBL] [Abstract][Full Text] [Related]
2. [Local thrombolysis in peripheral arterial occlusion]. Hess H Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076 [TBL] [Abstract][Full Text] [Related]
3. Coagulation alterations due to local fibrinolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease. Rauber K; Heidinger KS; Kemkes-Matthes B Cardiovasc Intervent Radiol; 1997; 20(3):169-73. PubMed ID: 9134838 [TBL] [Abstract][Full Text] [Related]
4. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of Rt-pa thrombolysis combined with PGE1 in patients with peripheral arterial occlusions. Kröger K; Buss C; Rudofsky G Angiology; 2000 May; 51(5):377-84. PubMed ID: 10826854 [TBL] [Abstract][Full Text] [Related]
6. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
7. [Local low dosage thrombolysis with rt-PA. Systemic effects on the fibrinolytic system--data on the assessment of the value and risk of this method]. von Bilderling P; Spannagl M; Mietaschk A; Iven M; Schramm W; Hess H Vasa Suppl; 1991; 33():132-3. PubMed ID: 1788645 [TBL] [Abstract][Full Text] [Related]
8. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
9. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance]. Wu WD; Xu YH; Tan PY Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647 [TBL] [Abstract][Full Text] [Related]
10. Procoagulant effects of thrombolytic therapy in acute myocardial infarction. Wang Y; Liu Q; Zhu J; Yuan Z; Ma X Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883 [TBL] [Abstract][Full Text] [Related]
11. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013 [TBL] [Abstract][Full Text] [Related]
12. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome. Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of urokinase and tissue-type plasminogen activator in transcatheter arterial fibrinolysis]. Vignali C; Cioni R; Mascalchi M; Russo R; Palla A; Lencioni R; Napoli V; Bartolozzi C Radiol Med; 1994; 88(1-2):93-9. PubMed ID: 8066262 [TBL] [Abstract][Full Text] [Related]
15. Peripheral arterial occlusions: local low-dose thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA). Hess H; Mietaschk A; von Bilderling P; Neller P Eur J Vasc Endovasc Surg; 1996 Jul; 12(1):97-104. PubMed ID: 8696906 [TBL] [Abstract][Full Text] [Related]
16. [Low-dose thrombolysis using rt-Pa in extensive peripheral vascular occlusion]. Jung EM; Lutz R; Rupp N Rofo; 2000 Dec; 172(12):1028-34. PubMed ID: 11199431 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator. Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898 [TBL] [Abstract][Full Text] [Related]
18. [Thrombolysis of acute arterial occlusion with rt PA]. Kurtoğlu M; Granit V; Necefli A; Kurtoğlu M; Güloğlu R Ulus Travma Derg; 2001 Jul; 7(3):158-62. PubMed ID: 11705216 [TBL] [Abstract][Full Text] [Related]